AACR 2013 - Antiprogestin Drug Developement: In Vitro Validation of a Potential Clinical Biomarker

E. Gillesa, L. Caplierb, A. Valentc, G. Serind, A. Gompele, J. Boscqc, and A. Zukiwskif  

aInvivis Pharmaceuticals, bBiodoxis, cInstitut Gustave Roussy, dOncodesign, e INSERM UMRS 938, fArno Therapeutics


By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.